{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:34:26Z","timestamp":1790890466098,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T00:00:00Z","timestamp":1612828800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Tuberculosis and Other Mycobacterial Diseases"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jctube.2021.100223","type":"journal-article","created":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T14:55:10Z","timestamp":1613400910000},"page":"100223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Evaluation of the performance of QuantiFERON\u00ae-TB Gold plus test in active tuberculosis patients"],"prefix":"10.1016","volume":"23","author":[{"given":"Cengiz","family":"\u00c7avu\u015fo\u011flu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8913-2314","authenticated-orcid":false,"given":"Melike","family":"Ya\u015far-Duman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Sezai Ta\u015fbakan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meltem","family":"I\u015f\u0131kg\u00f6z-Ta\u015fbakan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Nurullah Orman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jctube.2021.100223_b0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002152","article-title":"The global burden of latent Tuberculosis infection: A re-estimation using mathematical modelling","volume":"13","author":"Houben","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/j.jctube.2021.100223_b0010","series-title":"Mandell, Douglas and Bennet\u2019s principles and practice of infectious diseases","first-page":"2787","article-title":"Mycobacterium tuberculosis","author":"Fitzgerald","year":"2015"},{"issue":"5","key":"10.1016\/j.jctube.2021.100223_b0015","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jinf.2020.02.009","article-title":"Effect of HIV-infection on QuantiFERON-plus accuracy in patients with active tuberculosis and latent infection","volume":"80","author":"Petruccioli","year":"2020","journal-title":"J Infect"},{"issue":"RR-5","key":"10.1016\/j.jctube.2021.100223_b0020","first-page":"1","article-title":"IGRA expert committee; Centers for Disease Control and Prevention (CDC). Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection-United States","volume":"59","author":"Mazurek","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jctube.2021.100223_b0025","unstructured":"T.C. Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131, T\u00fcberk\u00fcloz Tan\u0131 ve Tedavi Rehberi. Art\u01316 Medya Tan\u0131t\u0131m Matbaa Ltd. \u015eti. 2. Bask\u0131 Ankara \u2013 2019 (in Turkish)."},{"key":"10.1016\/j.jctube.2021.100223_b0030","unstructured":"World Health Organization. Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings, Geneva, Switzerland, 2011."},{"key":"10.1016\/j.jctube.2021.100223_b0035","unstructured":"World Health Organization. Global tuberculosis report 2019, https:\/\/www.who.int\/tb\/publications\/global_report\/en\/ 2019 [accessed 30 August 2020]."},{"issue":"4","key":"10.1016\/j.jctube.2021.100223_b0040","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/infdis\/jir410","article-title":"Interferon-\u03b3 release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis","volume":"204","author":"Metcalfe","year":"2011","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.jctube.2021.100223_b0045","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1002\/eji.201243262","article-title":"Mycobacterium tuberculosis-specific CD8+ T cells are functionally and phenotypically different between latent infection and active disease","volume":"43","author":"Rozot","year":"2013","journal-title":"Eur J Immunol"},{"issue":"5","key":"10.1016\/j.jctube.2021.100223_b0050","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.4049\/jimmunol.1101122","article-title":"Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load","volume":"187","author":"Day","year":"2011","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.jctube.2021.100223_b0055","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.4049\/jimmunol.1000399","article-title":"Polyfunctional CD4(+) and CD8(+) T cell responses to tuberculosis antigens in HIV-1-infected patients before and after anti-retroviral treatment","volume":"184","author":"Sutherland","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jctube.2021.100223_b0060","unstructured":"Qiagen. QuantiFERONw-TB Gold Plus (QFT-Plus) ELISA package insert. Hilden, Germany: Qiagen, 2015. http:\/\/www.quantiferon.com\/irm\/content\/PI\/QFT\/PLUS\/2PK-Elisa\/UK.pdf Accessed August 2020."},{"issue":"3","key":"10.1016\/j.jctube.2021.100223_b0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032482","article-title":"Interferon-\u03b3 release assays for the diagnosis of tuberculosis and tuberculosis infection in HIV-infected adults: a systematic review and meta-analysis","volume":"7","author":"Santin","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jctube.2021.100223_b0070","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10238-012-0192-7","article-title":"Negative effect of immunosuppressive therapy in the performance of the QuantiFERON gold in-tube test in patients with immune-mediated inflammatory diseases","volume":"13","author":"Ramos","year":"2013","journal-title":"Clin Exp Med"},{"issue":"6","key":"10.1016\/j.jctube.2021.100223_b0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129792","article-title":"Factors that predict negative results of QuantiFERON-TBGold in-tubetest in patients with culture-confirmed tuberculosis: a multicenter retrospective cohort study","volume":"10","author":"Kwon","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jctube.2021.100223_b0080","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jinf.2011.09.008","article-title":"Questionable role of interferon-gamma assays for smear-negative pulmonary TB in immunocompromised patients","volume":"64","author":"Jung","year":"2012","journal-title":"J Infect"},{"issue":"3","key":"10.1016\/j.jctube.2021.100223_b0085","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.diagmicrobio.2011.02.011","article-title":"Risk factors for false-negative results of QuantiFERON-TB Gold In-Tube assay in non-HIV-infected patients with culture-confirmed tuberculosis","volume":"70","author":"Kim","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"6","key":"10.1016\/j.jctube.2021.100223_b0090","doi-asserted-by":"crossref","first-page":"690","DOI":"10.5588\/ijtld.16.0764","article-title":"The sensitivity of the QuantiFERON-TB Gold Plus assay in Zambian adults with active tuberculosis","volume":"21","author":"Telisinghe","year":"2017","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jctube.2021.100223_b0095","doi-asserted-by":"crossref","first-page":"30617","DOI":"10.1038\/srep30617","article-title":"Evaluation of QuantiFERON-TB gold plus for detection of Mycobacterium tuberculosis infection in Japan","volume":"6","author":"Yi","year":"2016","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.jctube.2021.100223_b0100","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3904\/kjim.2019.002","article-title":"QuantiFERON-TB Gold PLUS versus QuantiFERON- TB Gold In-Tube test for diagnosing tuberculosis infection","volume":"35","author":"Kim","year":"2020","journal-title":"Korean J Intern Med"},{"issue":"12","key":"10.1016\/j.jctube.2021.100223_b0105","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.21037\/jtd.2019.12.11","article-title":"Comparison of QFT-Plus and QFT-GIT tests for diagnosis of M. tuberculosis infection in immunocompetent Korean subjects","volume":"11","author":"Hong","year":"2019","journal-title":"J Thorac Dis"},{"issue":"1","key":"10.1016\/j.jctube.2021.100223_b0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053330","article-title":"Interferon gamma release assays for the diagnosis of latent TB infection in HIV-infected individuals in a low TB burden country","volume":"8","author":"Cheallaigh","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jctube.2021.100223_b0115","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1128\/CMR.00034-13","article-title":"Gamma interferon release assays for detection of Mycobacterium tuberculosis infection","volume":"27","author":"Pai","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jctube.2021.100223_b0120","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3389\/fimmu.2014.00180","article-title":"Functional signatures of human CD4 and CD8 T cell responses to Mycobacterium tuberculosis","volume":"5","author":"Prezzemolo","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.jctube.2021.100223_b0125","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.jinf.2016.09.008","article-title":"First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB Plus","volume":"73","author":"Petruccioli","year":"2016","journal-title":"J Infect"},{"issue":"5","key":"10.1016\/j.jctube.2021.100223_b0130","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.4049\/jimmunol.1200994","article-title":"CD4+ T cell dependent IFN-\u03b3 production by CD8+ effector T cells in M. tuberculosis infection","volume":"189","author":"Tyler","year":"2012","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.jctube.2021.100223_b0135","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1183\/13993003.02033-2015","article-title":"First independent evaluation of QuantiFERON-TB Plus performance","volume":"47","author":"Barcellini","year":"2016","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.jctube.2021.100223_b0140","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jinf.2019.08.018","article-title":"QuantiFERON TB Gold Plus for the diagnosis of tuberculosis: a systematic review and meta-analysis","volume":"79","author":"Sotgiu","year":"2019","journal-title":"J Infect"},{"key":"10.1016\/j.jctube.2021.100223_b0145","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.cmi.2016.05.006","article-title":"Equal sensitivity of the new generation QuantiFERON-TB Gold plus in direct comparison with the previous test version QuantiFERON-TB Gold IT","volume":"22","author":"Hoffmann","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.jctube.2021.100223_b0150","doi-asserted-by":"crossref","first-page":"115","DOI":"10.5578\/mb.53842","article-title":"Evaluation of QuantiFERON\u00ae-TB gold in tube test and tuberculin skin test in the diagnosis of Mycobacterium tuberculosis infection","volume":"51","author":"\u00c7avu\u015fo\u011flu","year":"2017","journal-title":"Mikrobiyol Bul"},{"key":"10.1016\/j.jctube.2021.100223_b0155","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.tube.2017.11.014","article-title":"A multicentre verification study of the QuantiFERON (\u00ae)-TB Gold Plus assay","volume":"108","author":"Pieterman","year":"2018","journal-title":"Tuberculosis"},{"key":"10.1016\/j.jctube.2021.100223_b0160","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.tube.2017.06.002","article-title":"Analytical evaluation of QuantiFERON-Plus and QuantiFERON-Gold In-Tube assays in subjects with or without tuberculosis","volume":"106","author":"Petruccioli","year":"2017","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.jctube.2021.100223_b0165","doi-asserted-by":"crossref","first-page":"e00427","DOI":"10.1128\/JCM.00427-18","article-title":"The Infection Control Society of Taiwan. QuantiFERON-TB Gold Plus is a more sensitive screening tool than QuantiFERON-TB Gold In-Tube for latent tuberculosis infection among older adults in long-term care facilities","volume":"56","author":"Chien","year":"2018","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.jctube.2021.100223_b0170","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.diagmicrobio.2012.11.023","article-title":"Antigen-specific CD4- and CD8-positive signatures in differ- ent phases of Mycobacterium tuberculosis infection","volume":"75","author":"Nikolova","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"7","key":"10.1016\/j.jctube.2021.100223_b0175","doi-asserted-by":"crossref","first-page":"e00614","DOI":"10.1128\/JCM.00614-18","article-title":"Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB gold in-tube interferon gamma release assays in patients at risk for tuberculosis and in health care workers","volume":"56","author":"Theel","year":"2018","journal-title":"J Clin Microbiol"}],"container-title":["Journal of Clinical Tuberculosis and Other Mycobacterial Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405579421000127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405579421000127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:36:45Z","timestamp":1762501005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405579421000127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":35,"alternative-id":["S2405579421000127"],"URL":"https:\/\/doi.org\/10.1016\/j.jctube.2021.100223","relation":{},"ISSN":["2405-5794"],"issn-type":[{"value":"2405-5794","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the performance of QuantiFERON\u00ae-TB Gold plus test in active tuberculosis patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jctube.2021.100223","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100223"}}